首页> 美国卫生研究院文献>Clinical and Diagnostic Laboratory Immunology >Seroepidemiology of Polioviruses among University Students in Northern Italy
【2h】

Seroepidemiology of Polioviruses among University Students in Northern Italy

机译:意大利北部大学生脊髓灰质炎病毒的血清流行病学

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The widespread use of poliovirus vaccination schemes has led to a marked decline in the incidence of paralytic poliomyelitis worldwide, but wild poliovirus is still endemic in some developing countries, and in 2009 a total of 23 countries reported at least 1 case of poliomyelitis caused by wild-strain polio viruses. A serological survey was thus conducted on the immunological status against polioviruses of 318 young adults, classified by their country of origin. Immunity to poliomyelitis was assessed by neutralizing antibody titration in tissues cultured on microplates. The rate of seronegativity (≤1:8) in the study population was 26.7% for poliovirus type 1, 7.2% for type 2, and 22.6% for type 3. In our sample of 318 individuals, 219 (68.9%) were Italian and 99 (31.1%) were from outside the European Union (EU). The proportion of cases found seropositive to polioviruses 1 and 3 decreased significantly with older age; this age-related decrease was more evident in the Italian group than among the non-EU subjects. Any risk of the wild virus recurring and causing paralytic poliomyelitis must be prevented, keeping Europe polio free by means of appropriate immunological protection, until polio has been conclusively eradicated all over the world. Judging from our findings, it may be worth considering administering a fifth dose of polio vaccine to adolescents.
机译:脊髓灰质炎病毒疫苗接种计划的广泛使用已导致全世界麻痹性脊髓灰质炎的发病率显着下降,但野生脊髓灰质炎病毒在某些发展中国家仍很流行,2009年,共有23个国家报告至少有1例由脊髓灰质炎引起的脊髓灰质炎株脊髓灰质炎病毒。因此对318名年轻人的脊髓灰质炎病毒的免疫状况进行了血清学调查,按其原籍国分类。通过中和微孔板培养的组织中的抗体滴定来评估脊髓灰质炎的免疫力。在研究人群中,血清脊髓灰质炎的发生率(≤1:8)分别为1型脊髓灰质炎病毒26.7%,2型脊髓灰质炎7.2%,3型脊髓灰质炎22.6%。在我们的318人样本中,有219名(68.9%)为意大利人, 99(31.1%)来自欧盟以外的国家。随着年龄的增长,发现对脊髓灰质炎病毒1和3呈血清反应阳性的病例比例显着下降。与非欧盟受试者相比,这一年龄相关的下降在意大利人群中更为明显。必须防止野生病毒复发和引起麻痹性脊髓灰质炎的任何风险,并通过适当的免疫保护措施使欧洲的小儿麻痹症免于发作,直到在世界各地彻底根除小儿麻痹症为止。从我们的发现来看,可能值得考虑向青少年服用第五剂脊髓灰质炎疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号